The number of annual doses the Cell Shuttle produces depends on the length of the cell therapy manufacturing process. If the process takes two days, like T-charge, the CAR T platform from Novartis, the Cell Shuttle can produce up to 2,800 cell therapies annually. But if the process takes 14 days, seven times longer, the production is cut down to around 400 cell therapies per year.